A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)

Clinical trial NCT00092391 · COMPLETED

Trial details

NCT number: NCT00092391
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Measles Mumps Rubella Varicella

Start date: 1999-02-01
Primary completion: 2001-07-01
Enrollment: 1997

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.